ATTRACT analysis finds improved quality of life for iliofemoral DVT patients treated with PCDT
An analysis of data from the ATTRACT trial, published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL), reveals that quality of...
FDA approves first generics of Eliquis for prophylaxis of DVT and pulmonary embolism
The US Food and Drug Administration (FDA) has announced the approval of two applications for the first generics of Eliquis (apixaban) tablets, to reduce...
Multicentre study demonstrates efficacy of Surfacer system for achieving central venous access
Bluegrass Vascular Technologies, a private medical technology company focused on innovating devices and methods for vascular access procedures, has announced the publication of positive...
LUPA study confirms effectiveness of accelerated leg ulcer pathway in an urban population
“The goal needs to remain on improving healing, but also reduced recurrence in the long term,” said Stephen Black (Guy’s and St Thomas’ Hospital,...
